Survivin as Predictive Biomarker for RA
NCT03444623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2022-05-04
Summary
Purpose: to examine the possibility of using the onco-protein survivin as a predictive biomarker for identifying individuals at risk of developing rheumatoid arthritis within a cohort of patients seeking treatment for joint pain/stiffness. Secondly, to study survivin as a prognostic marker for joint destruction, refractory and highly active disease in patients with established RA.
Conditions
Sponsors & Collaborators
-
Vastra Gotaland Region
lead OTHER_GOV
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2023-06-30
- Completion
- 2023-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
NCT00213538 ·Status: COMPLETED
-
Synovial Fluid Bank From Arthritic Patients
NCT00512343 ·Status: RECRUITING
-
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
NCT02219347 ·Status: COMPLETED ·Phase: NA
-
Reduced Ultrasound Counts in Rheumatoid Arthritis
NCT02389283 ·Status: UNKNOWN
-
Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
NCT02742337 ·Status: UNKNOWN
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001375 ·Status: COMPLETED
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
NCT00512239 ·Status: RECRUITING
-
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
NCT01402661 ·Status: ENROLLING_BY_INVITATION
-
Very Early Versus Delayed Etanercept in Patients With RA
NCT02433184 ·Status: COMPLETED ·Phase: PHASE4
-
Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis
NCT06880146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA
NCT03649061 ·Status: COMPLETED ·Phase: PHASE4
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309 ·Status: WITHDRAWN
-
Predictive Analytics for Theranosis in RA
NCT02928276 ·Status: UNKNOWN ·Phase: NA
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
NCT01328522 ·Status: COMPLETED ·Phase: PHASE1
-
Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers
NCT02464384 ·Status: UNKNOWN ·Phase: NA
-
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
NCT06712628 ·Status: RECRUITING
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
NCT05552105 ·Status: COMPLETED ·Phase: NA